News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Trump and aides described the Iran rescue with religious language, provoking criticism and calls for an inspector-general review.
  • Russia reported its air defenses shot down 148 Ukrainian drones in a three-hour wave that damaged energy infrastructure and cut power to about 500,000 homes.
  • Gulf sovereign funds committed about $24 billion to support Paramount Skydance's proposed $81 billion acquisition of Warner Bros. Discovery.
  • Samsung expects near-record quarterly operating profit as memory-chip price gains linked to AI demand boost revenue.
  • The White House proposed a fiscal 2027 budget boosting defense spending by $500 billion and cutting non-defense programs about 10%.
  • U.S. futures slipped and oil rose after Trump warned Iran to reopen the Strait of Hormuz by Tuesday, raising risk of supply disruption.

Latest Articles

Myseum Brings Free Private Social Network to 10,000 Weddings Where Every Guest Becomes the Photographer

Myseum Brings Free Private Social Network to 10,000 Weddings Where Every Guest Becomes the Photographer

Myseum, Inc. (Nasdaq: MYSE) announced its initiative to deploy Picture Party, a privacy-first private social network platform, at 10,000 weddings. The service enables couples and guests to instantly share and view photos and videos in real time during the event via a dedicated app and QR codes, improving photo-sharing experience and privacy. The co…

Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied

Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied

Quantum BioPharma announced a significant legal win as the US District Court for the Southern District of New York denied a joint motion to dismiss its lawsuit accusing CIBC World Markets and RBC Dominion Securities of illegal market manipulation using spoofing techniques. The company alleges these actions manipulated its stock price between 2020 a…

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Onconetix, Inc. announced that Realbotix LLC expects to deliver 19 AI humanoid robots in March-May 2026 as it scales production, ahead of Onconetix's planned acquisition of Realbotix. The combined company will continue trading on Nasdaq following closing in late 2026, subject to approvals. This deal broadens Onconetix's business into AI robotics wh…

ZenaTech Initiates New Operations in Ukraine to Accelerate Production of Counter-UAS Interceptor Systems

ZenaTech Initiates New Operations in Ukraine to Accelerate Production of Counter-UAS Interceptor Systems

ZenaTech, Inc., a technology provider specializing in AI drones and related solutions, announces the setup of drone manufacturing operations in Ukraine to accelerate production of its cost-effective counter-UAS interceptor systems. The move strategically leverages Ukraine's aerospace expertise and battlefield experience to serve global defense cust…

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

Curanex Pharmaceuticals is broadening its drug development pipeline to include cancer cachexia, a serious and unmet supportive care condition in oncology patients. This expansion complements its existing focus on inflammatory and metabolic diseases, marking a strategic evolution toward a broader therapeutics company. The global market for cancer ca…

Leapmotor Sustains Four-Quarter Streak Above 100,000 Deliveries

Leapmotor Sustains Four-Quarter Streak Above 100,000 Deliveries

Leapmotor reported 110,155 new energy vehicle deliveries in the first quarter, a near 26% year-over-year increase and the company’s fourth consecutive quarter above 100,000 units. The Hangzhou-based automaker also delivered 50,029 vehicles in March and has set ambitious targets for domestic and overseas sales while expanding retail and service foot…

Booking After the 25-for-1 Split: A Tactical Long With Measured Upside

Booking After the 25-for-1 Split: A Tactical Long With Measured Upside

Booking Holdings completed a 25-for-1 forward split on 04/02/2026 that should amplify retail demand and liquidity. Fundamentals remain solid — high free cash flow, mid-20s P/E, and 2025 revenue and EPS growth — making a disciplined long the preferred trade over the next 45 trading days. Risk is real: macro travel shocks, TSA disruptions, and moment…

Catheter Precision Engages Strategic Advisor

Catheter Precision Engages Strategic Advisor

Catheter Precision, Inc. announced engagement of a strategic advisor to market its cardiac electrophysiology business for sale. This move intends to unlock shareholder value by monetizing legacy medical device assets and concentrating on the company's growing Flyte aviation platform. The cardiac electrophysiology products LockeT and VIVO, both FDA-…

Proem Acquisition Corp I Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 6, 2026

Proem Acquisition Corp I Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 6, 2026

Proem Acquisition Corp I, a Cayman Islands-based blank check company listed on Nasdaq, announced that beginning April 6, 2026, holders of its units from the initial public offering can separately trade the company's ordinary shares and warrants under the symbols PAAC and PAACW respectively. Units not separated will continue trading as PAACU. The co…

authID Announces Strategic Partnership with Formula5 to Deliver Biometric Identity Security for Microsoft-First Enterprises

authID Announces Strategic Partnership with Formula5 to Deliver Biometric Identity Security for Microsoft-First Enterprises

authID announces a collaboration with Formula5, a Microsoft specialist consultancy, to expand deployment of biometric identity verification and authentication solutions. The partnership targets enhanced security for workforce and customer environments within Microsoft-centric identity ecosystems, supporting Zero Trust architectures and enabling pas…

Tokyo Lifestyle Secures US$2.56 Million Investment from Private Strategic Investor to Strengthen Operations and Expansion in Hong Kong

Tokyo Lifestyle Secures US$2.56 Million Investment from Private Strategic Investor to Strengthen Operations and Expansion in Hong Kong

Tokyo Lifestyle Co., Ltd., a Nasdaq-listed retailer specializing in Japanese beauty, health, luxury, and collectible products, announced a $2.56 million strategic investment into its Hong Kong subsidiary to support store expansion and operational enhancements. The investor, also appointed General Manager, will drive local management improvements, o…

Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive

Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive

Cocrystal Pharma announced that its oral antiviral candidate CDI-988 has received FDA Fast Track designation for the treatment and prevention of norovirus infection. The designation accelerates the development and regulatory review process, highlighting CDI-988 as a promising solution against a widespread and impactful viral infection. A Phase 1b c…

NANO Nuclear’s KRONOS MMR™ Microreactor Advances to Critical Milestone Toward Reactor Deployment with the University of Illinois Urbana-Champaign Submission of a Construction Permit Application to the U.S. Nuclear Regulatory Commission

NANO Nuclear’s KRONOS MMR™ Microreactor Advances to Critical Milestone Toward Reactor Deployment with the University of Illinois Urbana-Champaign Submission of a Construction Permit Application to the U.S. Nuclear Regulatory Commission

NANO Nuclear Energy Inc. has submitted a Construction Permit Application (CPA) for its KRONOS MMR™ microreactor to the U.S. Nuclear Regulatory Commission. This critical milestone marks the transition of the KRONOS MMR™ from concept to a formally licensable, build-ready commercial reactor system. Partnering with the University of Illinois Urbana-Cha…